Shopping Cart
- Remove All
Your shopping cart is currently empty
Ambenonium (WIN 8077) is a competitive and reversible cholinesterase AChE inhibitor with the advantage of being orally available with an IC50 = 0.7 nM for the treatment of myasthenia gravis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $293 | In Stock | |
| 5 mg | $722 | In Stock | |
| 10 mg | $987 | In Stock | |
| 25 mg | $1,520 | In Stock | |
| 50 mg | $1,980 | In Stock | |
| 100 mg | $2,500 | In Stock |
| Description | Ambenonium (WIN 8077) is a competitive and reversible cholinesterase AChE inhibitor with the advantage of being orally available with an IC50 = 0.7 nM for the treatment of myasthenia gravis. |
| Targets&IC50 | AChE (human):0.0007 μM, BChE (human):8.2 μM |
| In vitro | Ambenonium inhibited human AChE with high potency (IC₅₀ = 0.0007 μM; Ellman’s method; 20 min incubation), and showed strong selectivity over BChE (IC₅₀ = 8.2 μM)[1]. |
| Synonyms | WIN8077, WIN 8077 |
| Molecular Weight | 537.57 |
| Formula | C28H42Cl2N4O2 |
| Cas No. | 7648-98-8 |
| Smiles | O=C(NCC[N+](CC=1C=CC=CC1Cl)(CC)CC)C(=O)NCC[N+](CC=2C=CC=CC2Cl)(CC)CC |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.